Theriva Biologics announces positive VIRAGE phase 2b results

Theriva Biologics announces positive VIRAGE phase 2b results

Source: 
Tip Ranks
snippet: 
  • Theriva Biologics announced positive Phase 2b trial results for VCN-01 in pancreatic cancer.
  • VCN-01 improved survival metrics and was well-tolerated, suggesting potential as a new therapy.